Skip to main content
OpenTrials
Completed

NCT Number: NCT04355923

Confinement and Spondyloarthritis Treatment

Evaluate the impact of confinement on treatment use in spondyloarthritis. Study hypothesis that with the confinement, subjects will stop their treatment. The main objective is to study the impact of confinement on treatment. And secondly to look for for specific psychological profile linked to the interruption of the treatment. the study population consists of patients with spondyloarthritis and belonging to a patient association (ACS). All patients over 18 are included. A mailing questionnaire will be send to all patients. data on diseases activity and treatment will be collected

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Nice

Nice, 06300, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • spondyloarthritis,
  • age over 18 ans
  • treatment by NSAID or biological treatment to be part of the patient association "ACS" (action contre les spondylarthropathies).

Treatment and study plan

Primary outcomes

  1. treatment use

    Time frame: 1 month

    treatment continuation

Secondary outcomes

  1. activity of disease

    Time frame: 1 week

    number of crisis

  2. psychological aspects

    Time frame: 1 month

    Ten Item Personality Inventory rated on a scale from 1, disagree strongly, to 7, agree strongly)

  3. psychological aspects

    Time frame: 1 month

    quality of life questionnaire (EQ-5D) evaluating mobility, self care, usual activity, pain and anxiety

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Official study title

Impact of Confinement on the Treatment of Spondyloarthritis.

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Apr 21, 2020
Registry last updated
Jun 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.